ISSN: 2155-9899
+44 1223 790975
Michael G. Hanna Jr Vaccinogen, Inc.Tanzania
Commentary Active (Patient Specific) Immunotherapy of Colon Cancer: A Transition from Preclinical Studies to Successful Clinical Trials Author(s): Michael G. Hanna JrMichael G. Hanna Jr DOI: 10.4172/2155-9899.1000269
PDF